2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Oral Session

[O17] Oral Session 17　Hepatobiliary / Pancreatic Cancer
【E】

Sat. Feb 19, 2022 10:10 AM - 11:30 AM Room 10 (Royal Room, 1F, The Prince Kyoto Takaragaike)

Chair：Masashi Kanai（Department of Therapeutic Oncology, Kyoto University），Naoki Sasahira（Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research）
Discussant：Satoshi Kobayashi（Department of Gastroenterology, Kanagawa Cancer Center）

[O17-4] A phase II study of nivolumab in combination with modified FOLFIRINOX for metastatic pancreatic cancer

○Masafumi Ikeda1, Chigusa Morizane2, Makoto Ueno3, Kentaro Sudo4, Yoshinori Hirashima5, Masataka Kuroda5, Yuki Fukuyama5, Takuji Okusaka2, Junji Furuse6 (1.Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, 2.Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, 3.Department of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center, 4.Division of Gastroenterology, Chiba Cancer Center, 5.Clinical Development Headquarters, Ono Pharmaceutical Co., Ltd., 6.Department of Medical Oncology, Kyorin University Faculty of Medicine)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password